Back

Two-year quality of life after acute pulmonary embolism: results from the FOCUS study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Acute pulmonary embolism: aftermath Pulmonary Embolism (PE) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Anna C Mavromanoli

University Medical Centre of the Johannes Gutenberg University, Mainz (Germany)

5 More presentations in this session

Presentation thumbnail
Predictors of acute pulmonary embolism-related hospitalizations - an artificial neural network analysis using a nationwide cohort in the United States
Doctor J. Verma (Sangrur, IN)
Abstract Slides Video
Presentation thumbnail
Cost-of-illness analysis of long-term healthcare resource utilization and disease burden in patients with pulmonary embolism: insights from the PREFER in VTE registry
Mr I. Farmakis (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Causes of death and predictors of long-term mortality after pulmonary embolism
Doctor M. Ebner (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Signs of chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: results from the FOCUS study
Doctor S. Barco (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Chronic thromboembolic pulmonary hypertension and mortality after venous thromboembolism: a nationwide population-based cohort study
Mr K. Bonnesen (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Acute pulmonary embolism: aftermath

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Burden and long-term impact of pulmonary embolism on health-related quality of life: a matched cohort study
thumbnail
Congress Presentation
How the latest clinical insights are transforming PE patient care
thumbnail
Congress Presentation
Radiological indicators of chronicity in patients with acute symptomatic pulmonary embolism treated with ultrasound-assisted catheter-directed thrombolysis: a study of 180 consecutive cases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources